Inter-individual variability in equine antibody responses to African snake venoms follows heavy-tailed distributions with implications for antivenom production.

Overview

• This study investigates the variability in antibody responses among horses used to produce antivenom against African snake venoms.
• It examines how the distribution of antibody levels affects the overall productivity of plasma used for antivenom manufacturing.

Background and Purpose

• Horses are commonly immunized with snake venoms to produce antibodies that are harvested and processed into antivenom.
• It is known that individual horses exhibit variability in their antibody responses, but the statistical nature and impact of this variability are not well understood.
• The study aims to quantify and analyze antibody titers across a group of horses immunized with venoms from key sub-Saharan African snakes, linking these antibody levels to plasma productivity.

Methodology

• Antibody titers were measured using ELISA (enzyme-linked immunosorbent assay) in 14 horses immunized with relevant snake venoms.
• Cumulative Plasma Productivity (CPP) was calculated by converting individual plasma volumes into titer-corrected equivalents, integrating both the quantity and quality (antibody titer) of plasma.
• The study pooled plasma sequentially according to productivity contribution to analyze the overall cohort’s plasma productivity distribution.
• Statistical distribution analysis was performed to determine which models best described the distribution of antibody responses and productivity among horses.
• An in vivo mouse model was used to evaluate venom-neutralizing potency of the plasma pools.

Key Findings

• The distribution of antibody responses and cumulative plasma productivity is right-skewed and heavy-tailed.
• The data better fit a log-normal distribution rather than a strict Pareto (power-law) distribution.
• Approximately 20-30% of the horses contributed nearly half of the total plasma productivity of the cohort, indicating a small number of animals have disproportionately high antibody titers and plasma output.
• Removing plasma from the lowest-productivity horses:
  • Did not significantly improve the venom-neutralizing potency of the pooled plasma when tested in mice.
  • Resulted in a significant reduction in total plasma volume available.
• This suggests low-responding horses add volume but do not increase the overall efficacy of the antivenom pool meaningfully.

Implications for Antivenom Production

• Understanding the heavy-tailed nature of antibody responses can help optimize plasma collection strategies by focusing resources on the most productive animals.
• However, excluding low-productivity horses may decrease total plasma volume without improving potency, indicating a trade-off in antivenom yield versus quality.
• Log-normal distribution models provide a useful framework for anticipating the productivity variance across horse cohorts.
• The findings help inform decision-making about herd management, immunization protocols, and plasma pooling to maximize antivenom manufacture efficiency.

Generalizability and Limitations

• The specific quantitative results (such as the 20-30% high productivity contribution) may vary with different cohorts or experimental conditions.
• Nonetheless, the qualitative conclusions about variability patterns and their impact on production are expected to hold under similar settings.
• Further studies on larger cohorts and with different venom types could strengthen these insights.